GA-CYBLE
6.8.2024 11:03:28 CEST | Business Wire | Press release
Cyble, a global leader in AI-powered Gen 3 Cyber Threat Intelligence and digital risk protection, is excited to announce the appointment of Ernest Fung as its new Chief Financial Officer (CFO).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240802353537/en/
Cyble Appoints Ernest Fung as Chief Financial Officer (Photo: Business Wire)
With a rich background in corporate finance and investment strategies, Ernest brings invaluable expertise and leadership to Cyble. His role will be instrumental in enhancing the company’s financial strategy and driving its global expansion.
Ernest’s distinguished career spans over two decades across several sectors. He previously served as Chief Investment Officer at GoTo Group, Indonesia’s largest technology company. where he led GoTo’s $1 billion IPO, and secured over $1.3 billion in funding in GoTo’s pre-IPO financing. Ernest also served as Chief Investment Officer at Tokopedia, the leading e-commerce company in Indonesia, where he led the $18 billion merger with Gojek to form GoTo Group. Prior to his leadership positions at GoTo and Tokopedia, Ernest led International Corporate Development at JD.com, one of the largest e-commerce companies in China, and was a Director of Technology Investment Banking at Citigroup.
Beenu Arora, CEO of Cyble, stated, “We are delighted to welcome Ernest to our executive team. His understanding of financial strategy for managing high-growth companies will be invaluable as we scale our operations globally.”
Manish Chachada, COO of Cyble, added, “Ernest’s expertise in financial management and his strategic vision will be crucial as we expand our product offerings.”
"I am excited to join Cyble, one of the most innovative cybersecurity companies in the world," said Ernest. "I look forward to working closely with the Cyble team to achieve the company’s vision."
Cyble has recently received significant accolades, including being named an Innovation Leader in the Frost Radar™: Cyber Threat Intelligence 2024 by Frost & Sullivan. The company was also recognized in three Gartner Hype Cycle™ reports for the DRPS category, featured in Forrester's ASM Landscape 2024 report, and highlighted as a leader in G2’s Dark Web Monitoring Providers grid.
About Cyble
Cyble, the world's fastest-growing Gen 3 cyber threat intelligence company, offers comprehensive coverage across adversaries, infrastructure, exposures, weaknesses, and targets. Leveraging AI and ML, Cyble provides critical intelligence to help governments and enterprises protect citizens and infrastructure. Headquartered in Atlanta, Georgia, Cyble also has offices in Australia, Malaysia, Singapore, Dubai, Saudi Arabia, and India.
To learn more visit http://www.cyble.com/request-demo
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240802353537/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Angelini Pharma and Quiver Bioscience Announce Strategic Research Collaboration and Licensing Agreement to Discover and Advance Novel Therapeutics for Genetic Epilepsies23.2.2026 14:08:00 CET | Press release
Angelini Pharma secures exclusive global license rights to future identified drug targets Quiver receives undisclosed advance payment and is eligible for future milestone-dependent payments and royalties Collaboration further expands Angelini Pharma’s focus on brain health, building on its deep therapeutic expertise and drug development experience Angelini Pharma, part of the privately owned Angelini Industries, and Quiver Bioscience (“Quiver”), a discovery technology and therapeutics company advancing programs for the treatment of central nervous system (CNS) disorders, announced today that they have entered into a collaboration and licensing agreement to advance novel therapeutics for genetic epilepsies. The collaboration brings together Quiver’s unique drug discovery capabilities, data assets, and AI models with Angelini Pharma’s established expertise in brain health and epilepsy drug development. This press release features multimedia. View the full release here: https://www.busine
Armis Achieves U.S. Department of Defense Impact Level 5 Authorization23.2.2026 14:00:00 CET | Press release
DoD customers can now leverage Armis Centrix™ with enhanced security controls and connectivity Armis, the cyber exposure management & security company, today announced that it has achieved authorization from the U.S. DoD’s Defense Information Systems Agency (DISA) to operate at an Impact Level 5 (IL5). This means that Armis has met strict requirements to manage and secure the DoD’s critical infrastructure, including Controlled Unclassified Information (CUI) systems. “We are committed to helping Federal agencies like the Department of Defense address their toughest cybersecurity challenges,” said Alex Mosher, President and CRO at Armis. “Achieving DISA IL5 authorization is an important milestone for Armis as we continue to support DoD customers in safeguarding critical systems, sensitive data and national security infrastructure from evolving cyber threats.” Armis empowers Federal agencies to build and optimize comprehensive cybersecurity programs with Armis Centrix™, the FedRAMP and DI
IQM, a Global Leader for Quantum Computing, to Become the First Listed European Quantum Company, Through Merger with Real Asset Acquisition Corp.23.2.2026 13:49:00 CET | Press release
Global commercial leader with 21 systems sold to 13 customers to date – including 4 out of the top 10 supercomputing centres globally. Industrial leader with 15 systems delivered (largest number publicly disclosed by selected quantum companies1), 30+ computers built, own chip factory and quantum data centre. The transaction values IQM at a pre-money equity valuation of approximately USD 1.8 billion and makes IQM the first European quantum company to go public. With the close of this transaction, IQM’s cash position expected to exceed USD 450 million.2 Significant business momentum, with at least USD 35 million3 2025 revenue (unaudited) and over USD 100 million bookings / visibility as of year-end 2025. Strong commercial integrations with high-performance computing and enterprise platforms across the quantum/AI value chain such as NVIDIA, Hewlett Packard Enterprise, AWS, Toyo Corporation and Bechtle AG. Technical successes, achieving greater than 99.9% fidelity for single-qubit and two-
Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device23.2.2026 13:30:00 CET | Press release
MIUDELLA® is a strategic addition to Organon’s portfolio, strengthening its long‑term commitment to advancing women’s health Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that it has entered into an agreement to exclusively license global rights to MIUDELLA, Sebela Pharmaceuticals’ hormone-free copper intrauterine device (IUD) contraceptive. The effectiveness of this transaction is subject to review under the Hart-Scott-Rodino Antitrust Improvements Act and to U.S. Food and Drug Administration (FDA) approval of MIUDELLA's alternate supply chain entities and certain other conditions. MIUDELLA, the first hormone-free copper IUD approved in the U.S. in the last 40 years, is complementary to Organon’s commercial capabilities and would further Organon’s commitment to building a portfolio of products that meet women’s diverse reproductive health needs. MIUDELLA was approved by the FDA on
Lenovo Unlocks Data Potential with Next Generation of AI-Driven ThinkEdge Solutions23.2.2026 12:00:00 CET | Press release
New ThinkEdge devices deliver scalable, rugged, and versatile intelligence from gateway to high-performance edge for real-time insights Lenovo™ expanded its ThinkEdge portfolio with a new generation of AI-driven edge computing solutions, including the compact and reliable ThinkEdge SE10n Gen 2, the AI-ready ThinkEdge SE30n Gen 2, the AI-powerhouse ThinkEdge SE60n Gen 2, and Lenovo’s first industrial all-in-one (AIO) Panel PC, the ThinkEdge SE50a. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260223166717/en/ ThinkEdge SE10n Gen 2 As enterprises push intelligence closer to operations to improve resilience, reduce latency, and keep sensitive data local, edge computing has become a critical layer between devices, infrastructure, and cloud. Lenovo’s ThinkEdge solutions are purpose-built, industrial-grade edge systems designed to run reliably in harsh, space-constrained environments where traditional servers or PCs are impractic
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom